医学
骨关节炎
慢性疼痛
不利影响
疾病
伤害
关节痛
纤维肌痛
止痛药
物理疗法
重症监护医学
物理医学与康复
生物信息学
替代医学
麻醉
药理学
内科学
病理
受体
生物
作者
Sara Vieira Goncalves,Peter R.W. Gowler,Stephen G. Woodhams,James Turnbull,Gareth J. Hathway,Victoria Chapman
标识
DOI:10.1016/j.neuropharm.2022.109075
摘要
Osteoarthritis (OA) is a chronic joint disease that represents an increasingly substantial global burden. Joint pain is the most significant symptom of OA. Unfortunately, current pharmacological treatments for OA pain are often not wholly efficacious, or are associated with serious adverse effects. This lack of effective pain relief has seen the prescription of opioids for OA pain increase over the past decades. The long-term adverse effects of prescribed opioids alongside the increasing prevalence of OA pain highlights the need for alternative analgesics. Understanding the mechanisms that drive this chronic joint pain is crucial for the development of novel analgesics. OA is a heterogeneous disease, and this is reflected by the diversity of pain phenotypes in people with the disease. Herein, we review current understanding of the biological changes at the joint and within the central nervous system that drive this chronic pain. We particularly focus on the most recent advances in our understanding of the peripheral nociceptive mechanisms that underlie chronic OA pain and highlight how targeting peripheral OA inflammation may open up opportunities for novel analgesics.
科研通智能强力驱动
Strongly Powered by AbleSci AI